Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Verve Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 101 | 124 | +23 |
| Shares | 45.6M | 60.7M | +15.1M (+33.2%) |
| Value | $695.8M | $2.08B | +$1.39B (+199.3%) |
New holders (44)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Verve Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 371,671 | $5.68M |
| Renaissance Technologies LLC | 311,200 | $4.75M |
| ExodusPoint Capital Management, LP | 114,117 | $1.74M |
| EcoR1 Capital, LLC | 98,593 | $1.51M |
| Ergoteles LLC | 74,000 | $1.13M |
| Two Sigma Investments, LP | 56,781 | $868.0K |
| Pinz Capital Management, LP | 51,800 | $792.0K |
| Marshall Wace, LLP | 50,499 | $772.0K |
| Alyeska Investment Group, L.P. | 45,000 | $688.0K |
| Squarepoint Ops LLC | 40,417 | $618.0K |
| Jump Financial, LLC | 37,700 | $576.0K |
| HRT Financial LP | 36,541 | $558.0K |
| 1623 Capital LLC | 26,999 | $413.0K |
| Gsa Capital Partners LLP | 25,544 | $390.0K |
| HighTower Advisors, LLC | 12,000 | $184.0K |
| Quantbot Technologies LP | 6,500 | $99.0K |
| Simplex Trading, LLC | 173 | $2.00K |
| State of Wyoming | 121 | $2.00K |
| Northwestern Mutual Wealth Management Co | 23 | $0 |
| Captrust Financial Advisors | 4 | $0 |
| Steward Financial Group LLC | 2 | $0 |